TY - JOUR
T1 - Serial Electrophysiological Studies in a Young Patient with Recurrent Ventricular Fibrillation
AU - BELHASSEN, B.
AU - PELLEG, A.
AU - MILLER, H. I.
AU - LANIADO, S.
PY - 1981/1
Y1 - 1981/1
N2 - A 28‐year‐old male with recurrent episodes of ventricular fibrillation, which were initiated by very early ventricular premature depolarizations with a normal QT interval, was subjected to three consecutive electrophysiological studies. During the first study, which was carried out to test the efficacy of amiodarone treatment, no ventricular arrhythmias could be induced. While on amiodarone therapy, the patient experienced another syncopal episode and therefore a second electrophysiological study was done. In that study, ventricular fibrillation was induced by ventricular stimulation. During the third study, which was carried out in order to evaluate the effect of the addition of quinidine to the ongoing amiodarone therapy, no more than three repetitive ventricular responses could be induced. The patient has been asymptomatic since the third study (fifteen months) with combined therapy of amiodarone and quinidine. The significance of the ability to induce ventricular fibrillation during an electrophysiological study is discussed as well as the value of such studies in determining the long‐term efficacy of antiarrhythmic drug therapy.
AB - A 28‐year‐old male with recurrent episodes of ventricular fibrillation, which were initiated by very early ventricular premature depolarizations with a normal QT interval, was subjected to three consecutive electrophysiological studies. During the first study, which was carried out to test the efficacy of amiodarone treatment, no ventricular arrhythmias could be induced. While on amiodarone therapy, the patient experienced another syncopal episode and therefore a second electrophysiological study was done. In that study, ventricular fibrillation was induced by ventricular stimulation. During the third study, which was carried out in order to evaluate the effect of the addition of quinidine to the ongoing amiodarone therapy, no more than three repetitive ventricular responses could be induced. The patient has been asymptomatic since the third study (fifteen months) with combined therapy of amiodarone and quinidine. The significance of the ability to induce ventricular fibrillation during an electrophysiological study is discussed as well as the value of such studies in determining the long‐term efficacy of antiarrhythmic drug therapy.
KW - antiarrhythmic drug therapy
KW - electrophysiologic study
KW - syncope
KW - ventricular fibrillation
KW - ventricular premature depolarization
UR - http://www.scopus.com/inward/record.url?scp=0019365683&partnerID=8YFLogxK
U2 - 10.1111/j.1540-8159.1981.tb03680.x
DO - 10.1111/j.1540-8159.1981.tb03680.x
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0019365683
VL - 4
SP - 92
EP - 98
JO - PACE - Pacing and Clinical Electrophysiology
JF - PACE - Pacing and Clinical Electrophysiology
SN - 0147-8389
IS - 1
ER -